Julia F. Slejko

Julia F. Slejko, PhD, is an Associate Professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) at the University of Maryland School of Pharmacy. She serves as Co-Director of the Patient-Driven Values in Healthcare Evaluation (PAVE) Center and Director of the Pharmaceutical Health Services Research Graduate Program. Dr. Slejko is actively involved in ISPOR, where she co-leads the Women in HEOR initiative and serves on the Faculty Advisor Council and Health Science Policy Council.

• BA in Molecular, Cellular and Developmental Biology – University of Colorado Boulder
• PhD in Pharmacoeconomics – University of Colorado School of Pharmacy, Center for Pharmaceutical Outcomes Research
• Postdoctoral Training – Pharmaceutical Outcomes Research and Policy Program, University of Washington School of Pharmacy

Dr. Slejko’s research centers on health economic modeling and patient-informed value assessment. She investigates how real-world evidence, particularly medication adherence, influences cost-effectiveness analyses and healthcare decision-making. Her work integrates patient preferences into value frameworks, especially for chronic conditions like COPD, mental health disorders, and cancer. She also explores disparities in treatment outcomes related to socioeconomic and geographic factors.

Her recent publications (2020–2023) demonstrate a strong focus on patient-centered outcomes, microsimulation modeling, and economic burden analyses across oncology, psychiatry, and respiratory diseases. Themes include stakeholder engagement, treatment preferences, and the economic impact of comorbidities and health inequities.

Dr. Slejko mentors students through her role as faculty advisor for the UMB ISPOR Student Chapter and teaches graduate courses in research methods and pharmacoeconomics. She leads interdisciplinary research teams within the PAVE Center, fostering collaboration between patients, clinicians, and policymakers.

She has no listed scientific awards in the provided text, though her leadership roles suggest professional recognition. She advises on student research and is involved in grant-funded projects related to patient-driven value assessment, though specific grants are not detailed.